NK细胞极化在子宫内膜癌中的作用

doi:10.11904/j.issn.1002-3070.2021.06.009

实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (6): 534-537.doi: 10.11904/j.issn.1002-3070.2021.06.009

NK细胞极化在子宫内膜癌中的作用

牟冠男¹ 综述, 马强² 审校

1.哈尔滨医科大学附属肿瘤医院(哈尔滨 150081);
2.哈尔滨医科大学附属第二医院

收稿日期:2021-06-01 修回日期:2021-10-27 出版日期:2021-12-28 发布日期:2021-12-17
通讯作者: 牟冠男,E-mail:guannanmu@163.com
作者简介:牟冠男,女,(1987-),硕士,助理研究员,从事肿瘤免疫治疗的研究。
基金资助:
黑龙江省卫生计生委科研课题(编号:2018-472)

The role of NK cell polarization in endometrial cancer

MU Guannan¹, MA Qiang²

1. Harbin Medical University Cancer Hospital,Harbin 150081,China;
2. The Second Affiliated Hospital of Harbin Medical University

Received:2021-06-01 Revised:2021-10-27 Online:2021-12-28 Published:2021-12-17

摘要/Abstract

摘要： 自然杀伤(Natural killer,NK)细胞是一类具有细胞毒性的固有免疫细胞,被认为是主要的抗肿瘤效应细胞,但是NK细胞的功能在肿瘤的进展过程中发生了巨大的变化。子宫内膜癌(Endometrial cancer,EC)是女性生殖系统中最常见的肿瘤之一,免疫逃逸机制是EC进展的基础。在子宫内膜癌微环境中,细胞毒性NK细胞向肿瘤部位的募集减少,表型改变,杀伤功能降低,从而促进肿瘤生长和肿瘤血管生成。如何避免极化的微环境损害NK细胞的毒性,并且抑制促进肿瘤生长的NK细胞,成为我们关注的重点。

关键词: 自然杀伤细胞, 子宫内膜癌, 肿瘤微环境

Abstract: Natural killer(NK)cells are a type of cytotoxic innate immune cells and are considered as cells of the main effector, but the function of NK cells has undergone tremendous changes in the process of tumor progression.Endometrial cancer(EC)is one of the most common tumors in the female reproductive system, and the immune escape mechanism is at the basis for the progress of EC.Recent studies have found that the microenvironment of EC can not only reduce the recruitment of cytotoxic NK cells to the tumor site, but also change its phenotype and reduce its killing function.Moreover, NK cells with cytotoxicity in the tumor microenvironment gradually shift to an immune tolerance phenotype, which promotes tumor growth and tumor angiogenesis.How to prevent the polarized microenvironment from damaging the toxicity of NK cells and inhibiting the NK cells that promote tumor growth has become the focus of our attention.

Key words: Natural killer cells, Endometrial cancer, Tumor microenvironment

中图分类号:

R737

牟冠男, 马强. NK细胞极化在子宫内膜癌中的作用[J]. 实用肿瘤学杂志, 2021, 35(6): 534-537.

MU Guannan, MA Qiang. The role of NK cell polarization in endometrial cancer[J]. Journal of Practical Oncology, 2021, 35(6): 534-537.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.06.009

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I6/534

参考文献

1 McDonald ME,Bender DP.Endometrial cancer:obesity,genetics,and targeted agents[J].Obstet Gynecol Clin North Am,2019,46(1):89-105.
2 Cancer Genome Atlas Research Network,Kandoth C,Schultz N,et al.Integrated genomic characterization of endometrial carcinoma[J].Nature,2013,497(7447):67-73.
3 Drakes ML,Czerlanis CM,Stiff PJ.Immune checkpoint blockade in gynecologic cancers:state of affairs[J].Cancers(Basel),2020,12(11):3301.
4 Bruno A,Ferlazzo G,Albini A,et al.A think tank of TINK/TANKs:tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis[J].J Natl Cancer Inst,2014,106(8):200.
5 Carrega P,Morandi B,Costa R,et al.Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-)cells and display an impaired capability to kill tumor cells[J].Cancer,2008,112(4):863-875.
6 Bruno A,Bassani B,D’Urso DG,et al.Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic,decidual NK-like cells from patients with colorectal cancer[J].Faseb J,2018,32(10):5365-5377.
7 Tarazona R,Lopez-Sejas N,Guerrero B,et al.Current progress in NK cell biology and NK cell-based cancer immunotherapy[J].Cancer Immunol Immunother,2020,69(5):879-899.
8 Zhan L,Liu X,Zhang J,et al.Immune disorder in endometrial cancer:Immunosuppressive microenvironment,mechanisms of immune evasion and immunotherapy[J].Oncol Lett,2020,20(3):2075-2090.
9 Shreeve N,Depierreux D,Hawkes D,et al.The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice[J].Immunity,2021,54(6):1231-1244.
10 Fukui A,Yokota M,Funamizu A,et al.Changes of NK cells in preeclampsia[J].Am J Reprod Immunol,2012,67(4):278-286.
11 Versluis M A.C,Marchal S,Plat A,et al.The prognostic benefit of tumour-infiltrating natural killer cells in endometrial cancer is dependent on concurrent overexpression of human leucocyte antigen-E in the tumour microenvironment[J].Eur J Cancer,2017,86:285-295.
12 Albini A,Bruno A,Noonan DM,et al.Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment:implications for immunotherapy[J].Front Immunol,2018,9:527.
13 Close HJ,Stead LF,Nsengimana J,et al.Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma[J].Clin Exp Immunol,2020,200(1):33-44.
14 Wang L,Zhuang T,Li F,et al.Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway[J].Environ Sci Pollut Res Int,2019,26(26):27407-413.
15 Suh DH,Lee S,Park HS,et al.Medroxyprogesterone reverses tolerable dose Metformin-Induced inhibition of invasion via Matrix Metallopeptidase-9 and transforming growth factor-β1 in KLE endometrial cancer cells[J].J Clin Med,2020,9(11):3585.
16 Fionda C,Stabile H,Cerboni C,et al.Hitting more birds with a stone:impact of TGF-β on ILC activity in cancer[J].J Clin Med,2020,9(1):143.
17 Degos C,Heinemann M,Barrou J,et al.Endometrial tumor microenvironment alters human NK Cell recruitment,and resident NK Cell phenotype and function[J].Front Immunol,2019,10:877.
18 Chamoto K,Hatae R,Honjo T.Current issues and perspectives in PD-1 blockade cancer immunotherapy[J].Int J Clin Oncol,2020,25(5):790-800.
19 Pesce S,Belgrano V,Greppi M,et al.Different features of Tumor-Associated NK Cells in patients with low-grade or high-grade peritoneal carcinomatosis[J].Front Immunol[J],2019,10:1963.
20 Greppi M,Tabellini G,Patrizi O,et al.Strengthening the antiTumor NK Cell function for the treatment of ovarian cancer[J].Int J Mol Sci,2019,20(4):890.
21 Tumino N,Martini S,Munari E,et al.Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors:Functional analysis and expression of PD-1 receptor[J].Int J Cancer,2019,145(6):1660-1668.
22 Vari F,Arpon D,Keane C,et al.Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL[J].Blood,2018,131(16):1809-1819.
23 Post CCB,Westermann AM,Bosse T,et al.PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer[J].Crit Rev Oncol Hematol,2020,152:102973.
24 Lenhard M,Heublein S,Kunert-Keil C,et al.Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer[J].BMC Cancer,2013,13:616.
25 Scholz C,Heublein S,Lenhard M,et al.Glycodelin a is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients[J].BMC Res Notes,2012,5:551.
26 Lee CL,Vijayan M,Wang X,et al.Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype[J].Hum Reprod,2019,34(4):689-701.
27 Ricciuti B,Leonardi GC,Puccetti P,et al.Targeting indoleamine-2,3-dioxygenase in cancer:Scientific rationale and clinical evidence[J].Pharmacol Ther,2019,196:105-116.
28 Ino K,Yoshida N,Kajiyama H,et al.Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer[J].Br J Cancer,2006,95(11):1555-1561.
29 Ino K,Yamamoto E,Shibata K,et al.Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer:its association with disease progression and survival[J].Clin Cancer Res,2008,14(8):2310-2317.
30 Yoshida N,Ino K,Ishida Y,et al.Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model[J].Clin Cancer Res,2008,14(22):7251-7259.
31 Liu W,Sun L,Zhang J,et al.The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer[J].Biosci Rep,2021,41(4):20202321.
32 Zhou WJ,Chang KK,Wu K,et al.Rapamycin synergizes with cisplatin in antiendometrial cancer activation by improving IL-27-stimulated cytotoxicity of NK Cells[J].Neoplasia,2018,20(1):69-79.
33 André P,Denis C,Soulas C,et al.Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells[J].Cell,2018,175(7):1731-1743.
34 Marofi F,F Abdul-Rasheed OF,Rahman HS,et al.CAR-NK cell in cancer immunotherapy;a promising frontier[J].Cancer Sci,2021,112(9):3427-3436.

[1]	隆园辉, 陈雪松. 心理应激对肿瘤微环境中免疫细胞影响的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 436-440.
[2]	张慧婷, 娄阁. 卵巢癌肿瘤微环境的三维细胞培养模型研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 557-560.
[3]	李美艳, 陈永学, 侯俊德. Leptin、VEGF及不同麻醉方式对子宫内膜癌患者预后生存的影响[J]. 实用肿瘤学杂志, 2018, 32(5): 426-431.
[4]	李悦, 徐可, 韩增祥, 孙敏, 樊国华综述, 张勇审校. 结肠癌中肿瘤相关巨噬细胞的作用及靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 450-454.
[5]	吕强, 陈洪生, 李国东, 魏九峰(综述), 刘明(审校). 肿瘤相关成纤维细胞在大肠癌发生发展中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 275-279.
[6]	张培, 曹守波, 于雁. 自噬介导的肿瘤相关巨噬细胞调控机制的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 130-134.
[7]	毕琦玲, 周立红, 韩毅敏. HOX基因与妇科肿瘤的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 140-143.
[8]	龚伟, Md Tofiz Uddin, 陆佩欧, 于丽娟. PET/CT诊断子宫内膜癌的优势及展望[J]. 实用肿瘤学杂志, 2018, 32(2): 144-148.
[9]	雷婉婷, 王静萱. 肿瘤微环境在肿瘤细胞有氧糖酵解中的作用[J]. 实用肿瘤学杂志, 2018, 32(2): 189-192.
[10]	申美莹, 庞达. 长链非编码RNA在肿瘤微环境中的调控作用[J]. 实用肿瘤学杂志, 2018, 32(1): 73-76.
[11]	秦琪,徐洋,赵红,张清媛. 肿瘤相关中性粒细胞的研究进展[J]. 实用肿瘤学杂志, 2017, 31(4): 367-370.
[12]	徐洋，秦琪，赵红，刘健鸿综述，张清媛审校. 肿瘤微环境异质性的研究进展[J]. 实用肿瘤学杂志, 2017, 31(3): 258-261.
[13]	王明霞, 白治英, 耿俐. 高分化子宫内膜癌或非典型子宫内膜增生患者保守治疗后妊娠结局影响因素分析[J]. 实用肿瘤学杂志, 2016, 30(5): 409-413.
[14]	王涛, 郑永光, 范康武综述, 李玉民审校. 胃癌与肿瘤微环境的研究进展[J]. 实用肿瘤学杂志, 2014, 28(6): 561-564.
[15]	张百红综述,岳红云审校. 肿瘤的起源:局部或全身？[J]. 实用肿瘤学杂志, 2013, 27(5): 444-446.

NK细胞极化在子宫内膜癌中的作用

The role of NK cell polarization in endometrial cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价